Advanced Cell Therapies in Turkey

Personalized cellular therapy programs using advanced immune and regenerative cell technologies — including NK Cells, Muse Cells, Dendritic Cells, and CAR T-Cell based approaches. Available only after medical eligibility review.

Istanbul, Turkey
International Patient Support
Personalized Medical Assessment
Hospital & Clinic Coordination

Personalized Access to Advanced Cellular Therapy

At Turkey Stem Cell, we provide personalized access to advanced cellular therapy programs in Istanbul for carefully selected patients. These therapies may involve immune cell modulation, regenerative signaling, and targeted cellular approaches depending on the patient's diagnosis, medical history, treatment goals, and eligibility.

Every case is reviewed individually by our medical team. Treatment is offered only when, in the physician's clinical judgment, an advanced cellular program may be appropriate for that patient's specific medical context.

Treatment Overview

An honest summary of the advanced cellular therapy categories discussed during medical evaluation. None of these therapies are universally applicable; each requires physician review.

Natural Killer (NK) Cell Therapy

NK cells are innate immune cells that help identify abnormal or stressed cells. NK cell programs may be considered as part of immune-supportive or investigational cellular therapy plans, subject to physician evaluation and eligibility review.

Autologous NK Cells

Autologous NK cells are derived from the patient's own blood, prepared in a controlled laboratory process, and reintroduced under medical supervision. Suitability depends on the patient's immune cell quality and overall clinical profile.

Allogeneic NK Cells

Allogeneic NK cells are donor-derived and prepared under strict donor-screening and laboratory protocols. Their use depends on indication, availability, matching considerations, and physician review.

Muse Cells

Muse cells are stress-enduring, pluripotent-like cells currently being studied for regenerative medicine applications. Their use can be considered depending on the patient's medical condition and only after a full physician evaluation.

Dendritic Cell Therapy

Dendritic cells play a central role in immune system communication and antigen presentation. Dendritic cell–based approaches are commonly discussed in personalized immune therapy and oncology-related research settings.

CAR T-Cell Therapy

CAR T-cells are genetically modified T-cells engineered to recognize specific targets. CAR T-cell therapy is highly specialized and is available only after a detailed medical eligibility assessment.

Who May Request an Evaluation?

Advanced cellular therapies are not appropriate for everyone. The following are examples of clinical contexts where a medical evaluation may be requested:

  • Immune-focused cellular therapy programs
  • Oncology-related cellular therapy consultations
  • Regenerative medicine programs
  • Neurological or systemic conditions where advanced cell therapy may be discussed
  • Personalized treatment planning after standard care review

Requesting an evaluation does not guarantee treatment eligibility. Final decisions are made by the treating physician based on the complete medical assessment.

Autologous vs Allogeneic NK Cells

Autologous NK Cells

  • Derived from the patient's own blood
  • Personalized to the individual
  • Lower donor compatibility concerns
  • Requires sufficient patient immune cell quality

Allogeneic NK Cells

  • Sourced from a screened, healthy donor
  • Prepared under donor-screening protocols
  • May offer practical advantages in certain clinical settings
  • Requires medical, laboratory, and compatibility review

Why Choose Turkey Stem Cell

Istanbul-based international patient coordination
Personalized doctor evaluation for every case
Advanced cellular therapy planning
Hospital and clinic treatment coordination
Hotel, airport transfer, and translation support
Clear communication before, during, and after arrival
Ethical, medically supervised approach

Your Patient Journey

A simple, transparent five-step process from first contact to coordinated treatment in Istanbul.

1

Submit Medical Records

Share your diagnosis, recent reports, blood work, imaging, and treatment history with our medical coordinators.

2

Doctor Evaluation

Our physicians review your case individually and discuss whether an advanced cellular program may be appropriate.

3

Eligibility Review

Additional tests, imaging, or specialist opinions may be requested before any treatment plan is proposed.

4

Personalized Plan

If eligible, you receive a written plan covering the proposed therapy, schedule, expected costs, and clinical considerations.

5

Arrival & Coordination

We coordinate hospital admission, hotel, airport transfers, and translation throughout your stay in Istanbul.

Safety & Eligibility

Advanced cellular therapies require careful medical screening. Depending on the case, patients may need blood tests, imaging, oncology reports, genetic reports, medication review, and physician clearance before any cellular program is considered.

Active cancer, certain immune disorders, infections, blood disorders, and ongoing medications may affect eligibility. The treating physician will discuss potential risks, benefits, and limitations openly so patients can make informed decisions.

No clinical outcome can be guaranteed. All information shared during evaluation is for educational and clinical-planning purposes only and does not replace direct medical advice from your primary care team.

Frequently Asked Questions

Advanced cell therapies are medical approaches that use specialized cells or cell-based biological products to support immune, regenerative, or targeted therapeutic processes. Suitability depends on a full medical evaluation by the treating physician.

Natural Killer Cell Therapy involves NK cells, which are part of the innate immune system and help identify abnormal or stressed cells. NK cell-based programs may be considered after physician review and only when medically appropriate.

Autologous NK cells are derived from the patient's own blood, while allogeneic NK cells come from a screened donor source. Each option has different medical, laboratory, and compatibility considerations that must be reviewed by a physician.

Muse cells are stress-enduring cells currently being studied for regenerative medicine applications. Their use depends on the patient's condition, availability, and physician evaluation; they are not a guaranteed or universally applicable therapy.

Dendritic cell therapy is an immune-focused approach involving cells that help present information to the immune system. It is often discussed in personalized immune therapy and oncology-related research settings and requires careful eligibility review.

CAR T-cell therapy involves modifying a patient's T-cells to recognize specific targets. It is a highly specialized therapy that requires detailed eligibility assessment, hospital infrastructure, and physician oversight.

Yes. International patients can request a medical evaluation and receive support with treatment planning, hospital coordination, hotel arrangements, airport transfers, and translation services throughout their stay in Istanbul.

No. Results cannot be guaranteed. Every patient is different, and eligibility, risks, and expected outcomes must be reviewed individually by the medical team before any treatment is offered.

Request a Personalized Advanced Cell Therapy Evaluation

Send your diagnosis, recent medical reports, blood tests, imaging, and treatment history. Our medical team will review your case and advise whether an advanced cellular therapy program may be suitable.

Or call directly: +90 534 856 92 92